Clinical Operational Tolerance After Solid Organ Transplantation

P. Di Cocco, L. Bonanni, M. D'Angelo, K. Clemente, S. Greco, V. Rizza, C. Mazzotta, C. Scelzo, A. Famulari, F. Pisani, G. Orlando

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Clinical operational tolerance (COT) is a clinical condition obtainable with difficulty after solid organ transplantation (SOT). It is characterized by perfectly normal graft function in the total absence of maintenance immunosuppression. Major benefits deriving from the onset of COT are the reduction of risk for immunosuppression-related side effects and the improved quality of life. Currently, COT can be safely achieved in stable liver transplant recipients; it remains a challenge after renal transplantation. Only 1 case of COT has been reported after lung transplantation; no cases have been described after other types of SOT. Overall, mechanisms of COT are unclear and strategies to induce COT cannot be applied on a regular base to a large cohort of SOT recipients. Due to the failure of molecularly based tolerogenic protocols, great hope relies in the adoption of cell-based strategies.

Original languageEnglish
Pages (from-to)1278-1282
Number of pages5
JournalTransplantation Proceedings
Volume41
Issue number4
DOIs
Publication statusPublished - May 2009

Fingerprint

Organ Transplantation
Immunosuppression
Hope
Lung Transplantation
Risk Reduction Behavior
Kidney Transplantation
Maintenance
Quality of Life
Transplants
Liver

ASJC Scopus subject areas

  • Surgery
  • Transplantation
  • Medicine(all)

Cite this

Di Cocco, P., Bonanni, L., D'Angelo, M., Clemente, K., Greco, S., Rizza, V., ... Orlando, G. (2009). Clinical Operational Tolerance After Solid Organ Transplantation. Transplantation Proceedings, 41(4), 1278-1282. https://doi.org/10.1016/j.transproceed.2009.03.003

Clinical Operational Tolerance After Solid Organ Transplantation. / Di Cocco, P.; Bonanni, L.; D'Angelo, M.; Clemente, K.; Greco, S.; Rizza, V.; Mazzotta, C.; Scelzo, C.; Famulari, A.; Pisani, F.; Orlando, G.

In: Transplantation Proceedings, Vol. 41, No. 4, 05.2009, p. 1278-1282.

Research output: Contribution to journalArticle

Di Cocco, P, Bonanni, L, D'Angelo, M, Clemente, K, Greco, S, Rizza, V, Mazzotta, C, Scelzo, C, Famulari, A, Pisani, F & Orlando, G 2009, 'Clinical Operational Tolerance After Solid Organ Transplantation', Transplantation Proceedings, vol. 41, no. 4, pp. 1278-1282. https://doi.org/10.1016/j.transproceed.2009.03.003
Di Cocco P, Bonanni L, D'Angelo M, Clemente K, Greco S, Rizza V et al. Clinical Operational Tolerance After Solid Organ Transplantation. Transplantation Proceedings. 2009 May;41(4):1278-1282. https://doi.org/10.1016/j.transproceed.2009.03.003
Di Cocco, P. ; Bonanni, L. ; D'Angelo, M. ; Clemente, K. ; Greco, S. ; Rizza, V. ; Mazzotta, C. ; Scelzo, C. ; Famulari, A. ; Pisani, F. ; Orlando, G. / Clinical Operational Tolerance After Solid Organ Transplantation. In: Transplantation Proceedings. 2009 ; Vol. 41, No. 4. pp. 1278-1282.
@article{e12d7408cd874719afe13dce0d37645c,
title = "Clinical Operational Tolerance After Solid Organ Transplantation",
abstract = "Clinical operational tolerance (COT) is a clinical condition obtainable with difficulty after solid organ transplantation (SOT). It is characterized by perfectly normal graft function in the total absence of maintenance immunosuppression. Major benefits deriving from the onset of COT are the reduction of risk for immunosuppression-related side effects and the improved quality of life. Currently, COT can be safely achieved in stable liver transplant recipients; it remains a challenge after renal transplantation. Only 1 case of COT has been reported after lung transplantation; no cases have been described after other types of SOT. Overall, mechanisms of COT are unclear and strategies to induce COT cannot be applied on a regular base to a large cohort of SOT recipients. Due to the failure of molecularly based tolerogenic protocols, great hope relies in the adoption of cell-based strategies.",
author = "{Di Cocco}, P. and L. Bonanni and M. D'Angelo and K. Clemente and S. Greco and V. Rizza and C. Mazzotta and C. Scelzo and A. Famulari and F. Pisani and G. Orlando",
year = "2009",
month = "5",
doi = "10.1016/j.transproceed.2009.03.003",
language = "English",
volume = "41",
pages = "1278--1282",
journal = "Transplantation Proceedings",
issn = "0041-1345",
publisher = "Elsevier USA",
number = "4",

}

TY - JOUR

T1 - Clinical Operational Tolerance After Solid Organ Transplantation

AU - Di Cocco, P.

AU - Bonanni, L.

AU - D'Angelo, M.

AU - Clemente, K.

AU - Greco, S.

AU - Rizza, V.

AU - Mazzotta, C.

AU - Scelzo, C.

AU - Famulari, A.

AU - Pisani, F.

AU - Orlando, G.

PY - 2009/5

Y1 - 2009/5

N2 - Clinical operational tolerance (COT) is a clinical condition obtainable with difficulty after solid organ transplantation (SOT). It is characterized by perfectly normal graft function in the total absence of maintenance immunosuppression. Major benefits deriving from the onset of COT are the reduction of risk for immunosuppression-related side effects and the improved quality of life. Currently, COT can be safely achieved in stable liver transplant recipients; it remains a challenge after renal transplantation. Only 1 case of COT has been reported after lung transplantation; no cases have been described after other types of SOT. Overall, mechanisms of COT are unclear and strategies to induce COT cannot be applied on a regular base to a large cohort of SOT recipients. Due to the failure of molecularly based tolerogenic protocols, great hope relies in the adoption of cell-based strategies.

AB - Clinical operational tolerance (COT) is a clinical condition obtainable with difficulty after solid organ transplantation (SOT). It is characterized by perfectly normal graft function in the total absence of maintenance immunosuppression. Major benefits deriving from the onset of COT are the reduction of risk for immunosuppression-related side effects and the improved quality of life. Currently, COT can be safely achieved in stable liver transplant recipients; it remains a challenge after renal transplantation. Only 1 case of COT has been reported after lung transplantation; no cases have been described after other types of SOT. Overall, mechanisms of COT are unclear and strategies to induce COT cannot be applied on a regular base to a large cohort of SOT recipients. Due to the failure of molecularly based tolerogenic protocols, great hope relies in the adoption of cell-based strategies.

UR - http://www.scopus.com/inward/record.url?scp=65549145397&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65549145397&partnerID=8YFLogxK

U2 - 10.1016/j.transproceed.2009.03.003

DO - 10.1016/j.transproceed.2009.03.003

M3 - Article

C2 - 19460538

AN - SCOPUS:65549145397

VL - 41

SP - 1278

EP - 1282

JO - Transplantation Proceedings

JF - Transplantation Proceedings

SN - 0041-1345

IS - 4

ER -